CHG-WHtR

2 papers3 findings

Humans2

Associations

3

Cardiometabolic multimorbidity

upin humans1HR 1.61

1 study

CHG-WHtR raises the risk of cardiometabolic multimorbidity in humans (HR 1.61, 95% CI 1.57-1.65).
Humansin MASLD participantsn = 109,434
The cholesterol, high-density lipoprotein, and glucose index and its derived indices predict cardiometabolic multimorbidity development and progression in metabolic dysfunction-associated steatotic liver disease individuals: a prospective cohort study
Cardiovascular diabetology23 Aug 2026

More on Cardiometabolic multimorbidity

Cardiovascular mortality

upin humans1HR 2.02

1 study

CHG-WHtR predicts cardiovascular mortality in humans (HR 2.020 (95% CI 1.816-2.247) per 1-SD increase).
Humansin hypertensive participants
Predicting all-cause and cardiovascular mortality in hypertensive patients by combining the CHG index and its obesity indicators: a prospective cohort study with survival prediction model
Cardiovascular diabetology5 Aug 2026

Mortality

upin humans1HR 2.06

1 study

CHG-WHtR predicts mortality in humans (HR 2.060 (95% CI 1.852-2.292) per 1-SD increase).
Humansin hypertensive participants
Predicting all-cause and cardiovascular mortality in hypertensive patients by combining the CHG index and its obesity indicators: a prospective cohort study with survival prediction model
Cardiovascular diabetology5 Aug 2026

Latest

2 in 12 months

Cardiovascular Diabetology13 Sep

The cholesterol, high-density lipoprotein, and glucose index and its derived indices predict cardiometabolic multimorbidity development and progression in metabolic dysfunction-associated steatotic liver disease individuals: a prospective cohort study

Cohort study of 109,434 peopleCardiometabolic multimorbidity

Cardiovascular Diabetology8 Sep

Predicting all-cause and cardiovascular mortality in hypertensive patients by combining the CHG index and its obesity indicators: a prospective cohort study with survival prediction model

Cohort study of 4,661 peopleHypertension